一个案例报告关于USG导向的恒星性关节块在耐火性心室性心跳动
Anwesha Banerjee1, Anshuman Mishra1, Aarushi Batra2
1Department of Anesthesia and Pain Medicine, Yatharth Super Specialty Hospital, Greater Noida, Uttar Pradesh, India.
Journal of pharmacy & bioallied sciences
|July 14, 2025
概括
星状质块可以治疗上肢疼痛和耐火性心室动脉节律失常症. 超声波指导提高了这种可访问的床边治疗的安全性和有效性.
科学领域:
- 心脏病学 心脏病学
- 疼痛医学 医学 疼痛医学
- 神经学 神经学
背景情况:
- 星状质块被疼痛医生和麻醉师用于同情性疼痛障碍.
- 这种手术需要精确,因为节靠近重要的血管和神经结构.
更多相关视频
07:50Location, Dissection, and Analysis of the Murine Stellate Ganglion
Published on: December 22, 2020
10.8K
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
14.9K
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168
Drugs Acting on Autonomic Ganglia: Blockers
1.2K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.2K
Dysrhythmias VI: Management of Dysrhythmias
110
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
110
Mitral Stenosis III: Medical Management
27
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
27
